Colorectal cancer is one of the most prevalent tumors and a leading cause of cancer-related mortality. Despite advances ...

Experts discuss additional factors considered when determining the most effective sequence of therapies for metastatic colorectal cancer, including fruquintinib, regorafenib, and trifluridine + ...

FDA approves Guardant Health's blood test to help identify metastatic colorectal cancer patients eligible for targeted ...

This article is brought to you by Ochsner Health. While overall rates of colorectal cancer have been declining in the United States, the numbers have been steadily increasing among younger patients.

CX-2051 demonstrated a 28% overall response rate in advanced colorectal cancer, with a 43% response at the highest dose of 10 mg/kg. The disease control rate was 94%, and median progression-free ...

The results of the phase 3 ATOMIC trial fired another volley in the ongoing debate over adjuvant vs neoadjuvant immunotherapy for patients with locally advanced colon cancer. But experts are divided ...

Colorectal cancers have seen a 1% increase in deaths every year since 2005, while the mortality rate of every other type of ...

Most people with colon cancer begin treatment by having surgery to remove their cancer. If colon cancer has spread beyond your colon, you might have chemotherapy first. This can help treat cancer ...

Colon cancer has quietly moved into a grim new position in American health, overtaking other malignancies to become the ...

Fewer people under age 50 are dying from cancer in the U.S., but colorectal cancer mortality rates continue to surge ...

While overall rates of colorectal cancer have been declining in the United States, the numbers have been steadily increasing among younger patients. In fact, 1 out of 8 cancer patients treated for ...